HRL
41
2
IP
36
-6
IR
79
7
KSS
37
4
FITB
63
4
GRMN
61
2
DHI
52
8
SCHW
61
3
CAT
72
3
NTRS
32
2
AMAT
54
4
HST
55
5
URI
58
9
HON
63
3
BK
71
2
ALLE
32
2
SYK
59
22
SBUX
50
-2
DE
35
-3
WU
38
18
HRL
41
2
IP
36
-6
IR
79
7
KSS
37
4
FITB
63
4
GRMN
61
2
DHI
52
8
SCHW
61
3
CAT
72
3
NTRS
32
2
AMAT
54
4
HST
55
5
URI
58
9
HON
63
3
BK
71
2
ALLE
32
2
SYK
59
22
SBUX
50
-2
DE
35
-3
WU
38
18
Financhill
Back

Rocket Pharmaceuticals Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
50

RCKT
Rocket Pharmaceuticals

Last Price:
23.63
Seasonality Move:
26.74%
Sell
10

NBY
NovaBay Pharmaceuticals

Last Price:
0.07
Seasonality Move:
-10.02%
Sell
50
Rocket Pharmaceuticals (RCKT) is a Sell

Is Rocket Pharmaceuticals a Buy, Sell or Hold?

  • The current Rocket Pharmaceuticals [RCKT] share price is $23.67. The Score for RCKT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • RCKT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
10
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.08. The Score for NBY is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

RCKT Stock Price Chart

What is Rocket Pharmaceuticals's stock price today?

  • The Rocket Pharmaceuticals share price today is $23.67
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCKT is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.08
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.

RCKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.01 Sell
Relative Strength Index (14 RSI): 39.28 Sell
Chaikin Money Flow: -442546 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.91 - 26.85) Sell
Bollinger Bands (100): (25.4 - 29.56) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 29.3 Sell
Chaikin Money Flow: 968137 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.08 - 0.12) Sell
Bollinger Bands (100): (0.11 - 0.23) Sell

RCKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.74 Sell
20-day SMA: 24.9 Sell
50-day SMA: 27.01 Sell
200-day SMA: 23.04 Buy
8-day EMA: 23.86 Sell
20-day EMA: 24.78 Sell
50-day EMA: 26.08 Sell
200-day EMA: 24.25 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.08 Sell
20-day SMA: 0.09 Sell
50-day SMA: 0.12 Sell
200-day SMA: 0.34 Sell
8-day EMA: 0.08 Sell
20-day EMA: 0.09 Sell
50-day EMA: 0.12 Sell
200-day EMA: 0.58 Sell

Rocket Pharmaceuticals Earnings Growth & RCKT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.26 per share, an increase this year of $0.38 per share, and an increase next year of $0.83 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.04 per share, an increase this year of $2.04 per share, and an increase next year of $0.30 per share.

Rocket Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):